Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort.

MLA

Bertrand, Dominique, et al. “Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort.” Journal of Clinical Medicine, vol. 9, no. 11, Oct. 2020. EBSCOhost, https://doi.org/10.3390/jcm9113479.

APA

Bertrand, D., Terrec, F., Etienne, I., Chavarot, N., Sberro, R., Gatault, P., Garrouste, C., Bouvier, N., Grall-Jezequel, A., Jaureguy, M., Caillard, S., Thervet, E., Colosio, C., Golbin, L., Rerolle, J.-P., Thierry, A., Sayegh, J., Janbon, B., Malvezzi, P., … Noble, J. (2020). Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort. Journal of Clinical Medicine, 9(11). https://doi.org/10.3390/jcm9113479

Chicago

Bertrand, Dominique, Florian Terrec, Isabelle Etienne, Nathalie Chavarot, Rebecca Sberro, Philippe Gatault, Cyril Garrouste, et al. 2020. “Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort.” Journal of Clinical Medicine 9 (11). doi:10.3390/jcm9113479.